Government of the Republic of South Sudan Ministry of Health Juba South Sudan.
Department of Infectious Diseases The University of Melbourne, at The Peter Doherty Institute for Infection and Immunity Melbourne Australia.
Influenza Other Respir Viruses. 2023 Nov;17(11):e13200. doi: 10.1111/irv.13200.
The first few 'X' (FFX) studies provide evidence to guide public health decision-making and resource allocation. The adapted WHO Unity FFX protocol for COVID-19 was implemented to gain an understanding of the clinical, epidemiological, virological and household transmission dynamics of the first cases of COVID-19 infection detected in Juba, South Sudan.
Laboratory-confirmed COVID-19 cases were identified through the national surveillance system, and an initial visit was conducted with eligible cases to identify all close contacts. Consenting cases and close contacts were enrolled between June 2020 and December 2020. Demographic, clinical information and biological samples were taken at enrollment and 14-21 days post-enrollment for all participants.
Twenty-nine primary cases and 82 contacts were included in the analyses. Most primary cases (n = 23/29, 79.3%) and contacts (n = 61/82, 74.4%) were male. Many primary cases (n = 18/29, 62.1%) and contacts (n = 51/82, 62.2%) were seropositive for SARS-CoV-2 at baseline. The secondary attack rate among susceptible contacts was 12.9% (4/31; 95% CI: 4.9%-29.7%). All secondary cases and most (72%) primary cases were asymptomatic. Reported symptoms included coughing (n = 6/29, 20.7%), fever or history of fever (n = 4/29, 13.8%), headache (n = 3/29, 10.3%) and shortness of breath (n = 3/29, 10.3%). Of 38 cases, two were hospitalised (5.3%) and one died (2.6%).
These findings were used to develop the South Sudanese Ministry of Health surveillance and contract tracing protocols, informing local COVID-19 case definitions, follow-up protocols and data management systems. This investigation demonstrates that rapid FFX implementation is critical in understanding the emerging disease and informing response priorities.
最初的几个“X”(FFX)研究为公共卫生决策和资源分配提供了依据。为了了解在南苏丹朱巴首次发现的 COVID-19 感染的临床、流行病学、病毒学和家庭传播动态,对世界卫生组织针对 COVID-19 的统一 FFX 协议进行了调整,以此开展了该研究。
通过国家监测系统发现经实验室确诊的 COVID-19 病例,并对符合条件的病例进行初次访问,以确定所有密切接触者。在 2020 年 6 月至 2020 年 12 月期间,同意参与的病例及其密切接触者被纳入研究。所有参与者在入组时和入组后 14-21 天采集人口统计学、临床信息和生物样本。
共纳入 29 例原发性病例和 82 例接触者进行分析。大多数原发性病例(n=23/29,79.3%)和接触者(n=61/82,74.4%)为男性。许多原发性病例(n=18/29,62.1%)和接触者(n=51/82,62.2%)在基线时 SARS-CoV-2 血清抗体呈阳性。易感性接触者的继发感染率为 12.9%(4/31;95%CI:4.9%-29.7%)。所有继发性病例和大多数(72%)原发性病例均为无症状。报告的症状包括咳嗽(n=6/29,20.7%)、发热或有发热史(n=4/29,13.8%)、头痛(n=3/29,10.3%)和呼吸急促(n=3/29,10.3%)。38 例病例中,有 2 例(5.3%)住院,1 例(2.6%)死亡。
这些发现用于制定南苏丹卫生部的监测和接触者追踪协议,为当地 COVID-19 病例定义、随访协议和数据管理系统提供了依据。本研究表明,快速实施 FFX 对于了解新发疾病和确定应对重点至关重要。